Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

Returns on capital

Latigo Biotherapeutics Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

No return metrics data available.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Todd N. Smith

PresIdent, CEO & DirectorUSD 1.06M56105.54K0.16%

Nima Farzan

Executive OfficerUSD 1.06M50114.45K0.17%

Neil Kumar Singla

Chief Medical OfficerUSD 1.01M54——

Neha Krishnamohan

Chief Business Officer & CFOUSD 37.5K399.90K0.01%

Bryan Moyer

Senior Vice President of Discovery————

Caroline Dougherty

Vice President of Corporate Development————

Julia Chapman

Senior Vice President of Operations————

Polina German

Senior Vice President of Clinical Pharmacology & Translational————

Sabrina Nieder

VP & Corporate Controller————

Vicki Holloway

Secretary————

Compensation is shown in the reported currency; data updated Nov 18, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 6, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

2

$5.04M

Sells

0

$0.00

Net Transaction Value

+$5.04M

Net buying

Most Active

Foresite Capital Management V, LLC

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 10, 26

Foresite Capital Management V, LLC

Indirect

Buy$2.5M
Aug 10, 26

Tananbaum James B.

Indirect

Buy$2.5M

Summary

Insiders reported 2 buys worth $5.04M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $5.04M. Foresite Capital Management V, LLC was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

No growth data available

Competitors

Who does Latigo Biotherapeutics Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about LTGO's management, answered from reported figures.

Who manages LTGO?

Latigo Biotherapeutics Inc. (LTGO) lists 10 active executives. The top listed executive is Todd N. Smith, PresIdent, CEO & Director.

Are LTGO insiders buying or selling?

Recent insider activity shows net buying of $6.94M.